Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Delta Sleep Inducing Peptide: Research Application Comparison

The table below compares delta sleep inducing peptide to commonly confused sleep-related compounds across mechanism, research applications, and regulatory context. Delta Sleep Inducing Peptide (DSIP) GABA-A receptor modulation, HPA axis regulation, serotonin s

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • The table below compares delta sleep inducing peptide to commonly confused sleep-related compounds across mechanism, research applications, and regulatory context.
  • Delta Sleep Inducing Peptide (DSIP)
  • GABA-A receptor modulation, HPA axis regulation, serotonin stabilization
  • Stress-induced insomnia, circadian dysregulation, cortisol normalization studies
  • 30–60 min onset, 6–8 hr sleep architecture effect
  • Research-grade peptide, not FDA-approved for therapeutic use
  • Best for studies where sleep fragmentation stems from stress or circadian misalignment. Not a sedative replacement
  • Melatonin
  • SCN signaling, circadian phase adjustment
  • Jet lag, shift work disorder, sleep onset delay
  • 20–30 min onset, 4–6 hr duration
  • OTC supplement, GRAS status
  • Ideal for timing experiments. Does not improve sleep quality or delta wave percentage
  • Benzodiazepines (e.g., temazepam)
  • GABA-A positive allosteric modulation at benzodiazepine site
  • Acute insomnia, anxiety disorders
  • 15–30 min onset, 6–10 hr sedation
  • Prescription-only, DEA Schedule IV
  • Suppresses REM and slow-wave sleep. High dependency risk, poor choice for circadian or restorative sleep research
  • Selank Amidate Peptide
  • BDNF modulation, enkephalin stabilization, anxiolytic without sedation
  • Performance anxiety, chronic stress models, daytime hyperarousal
  • 30–90 min onset, 4–6 hr anxiolytic effect
  • Research-grade peptide
  • Complements DSIP in protocols addressing comorbid anxiety and sleep disruption
  • Epithalon Peptide
  • Telomerase activation, circadian gene expression (BMAL1, CLOCK)
  • Aging research, long-term circadian rhythm studies
  • No acute onset, effects accumulate over weeks
  • Addresses circadian drift at the genetic level. Not for acute sleep intervention

Related resources

More comparisons